Artiva Biotherapeutics Competitors and Similar CompaniesClear all

Immutep's competitors and similar companies include OncoTherapy Science and Bexion Pharmaceuticals.

	Immutep Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.	OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics.	Bexion Pharmaceuticals Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.
Founding Date	Founding Date 2001	Founding Date 2001	Founding Date 2006
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy	Tags Healthcare biotech drug development oncology therapy
Locations	Locations Sydney, AU HQ Sydney, AU The Rocks, AU Orsay, FR Berlin, DE Leipzig, DE	Locations Kawasaki, JP HQ	Locations Covington, US HQ
Employees	Employees 2427% decrease	Employees 54	Employees 274% increase
Valuation ($)	Valuation ($) 282.4 m	Valuation ($) 56.9 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥808.5m (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods ¥794.6m (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit $5m (FY, 2025)	Gross profit ¥14m (FY, 2026)	Gross profit N/A
Net income	Net income ($61.4m) (FY, 2025)	Net income (¥910.6m) (FY, 2026)	Net income N/A